Combined Treatment With a Transforming Growth Factor Beta Inhibitor (1D11) and Bortezomib Improves Bone Architecture in a Mouse Model of Myeloma-Induced Bone Disease
Bone - Netherlands
doi 10.1016/j.bone.2016.07.007
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Elsevier BV